Deep Tech Innovations: Improving the Human Condition [Online Event] | SGInnovate


Online Event

Deep Tech Innovations: Improving the Human Condition [Online Event]

Presented by SGInnovate and UNDP Global Centre for Technology, Innovation and Sustainable Development

Wearable monitors, rapid diagnostics kits and AI that can analyse thousands of CT scans illustrate the importance of Deep Tech innovations that can help deliver better patient outcomes - in particular, how scientists and startups can harness existing technologies to help contain and manage the novel coronavirus of our time.

In Bill Gates’ words, “the coronavirus pandemic pits all of humanity against the virus. The damage to health, wealth, and well-being has already been enormous.” This extraordinary global challenge demands a global response. Notably, the UNDP is leading the COVID-19 Detect and Protect Challenge to find the best and brightest of humanity, to work for those who will be hardest hit by this pandemic.

In another global initiative, the “Open COVID Pledge” urges companies to free their IP to help fight the COVID-19 pandemic, supported by global tech firms such as Intel, Microsoft, Amazon, Facebook, IBM, etc.

Join us at this online event as our panel of speakers shares their stories and perspectives on the promise of using Deep Tech for good, and opportunities for global collaborations for the benefit of humanity.

Date: 26 May 2020 (Tuesday)
Time: 10:30am – 11:30am (UTC+8)

10:30am – 10:35am: Opening Remarks by SGInnovate and the UNDP

  • Dr Lim Jui, CEO, SGInnovate
  • Bradley J Busetto, Director, UNDP Global Centre for Technology, Innovation and Sustainable Development

10:35am – 11:30am: Panel Discussion and Q&A


  • Bradley J Busetto, Director, UNDP Global Centre for Technology, Innovation and Sustainable Development
  • Prof Dean Ho, Provost’s Chair Professor and Director, The N.1 Institute for Health (N.1) Institute, National University of Singapore
  • Kuldeep Singh Rajpu, Founder & CEO, Biofourmis
  • Huub van Esbroeck, Founder, Structo

Moderator: Dr Lim Jui, CEO, SGInnovate

Speakers’ Profiles

Bradley J Busetto, Director, UNDP Global Centre for Technology, Innovation and Sustainable Development

Bradley leads the newly established UNDP Global Centre for Technology, Innovation and Sustainable Development in Singapore.

Bradley is regarded as a pioneer in creating and scaling innovative financing and business models for sustainable development. Bradley set up the UN’s first social venture incubator and impact investment fund, as well the world’s first national SDG Innovation Lab, during his tenure as UN RC/UNDP RR in Armenia (2013 - 2018).   This work was recognised by the Future of Innovation Summit (co-hosted by Stanford University/Rockefeller Foundation). On behalf of the international community in Armenia, Bradley also led a sensitive electoral assistance program that helped pave the way for the first free, and fair elections in the country’s history. He was awarded the Medal of Honour from the Minister of Foreign Affairs of Armenia.

Directly before his appointment in Singapore, he helped lead the design of UNDP’s pioneering flagship innovation lab network and helped craft the SDG Fund for the United Nations.  Previously with the UN, Bradley served in humanitarian missions in Indonesia, Iraq, Bosnia-Herzegovina and Kosovo.

In addition to his United Nations service, Bradley led the expansion of international operations for the Wellcome Trust, the leading global health foundation. He also worked in leadership roles in banking and management consulting and co-founded a startup. The California native holds a BA and a master’s degree in philosophy from Stanford University, where he graduated with honours.

Prof Dean Ho, Provost’s Chair Professor and Director, The N.1 Institute for Health (N.1) Institute, National University of Singapore

Prof Dean Ho is Provost's Chair Professor, Director of the N.1 Institute for Health (N.1), Director of the Institute for Digital Medicine (WisDM), and Head of the Department of Biomedical Engineering at the National University of Singapore. 
Using his CURATE.AI platform, Prof Ho has led multiple pioneering clinical studies that have validated the promise of N-of-1 medicine, where only a patient's data used to personalise their treatment for the entire duration of care. Multiple CURATE.AI-based clinical studies are ongoing or cleared for a start in the areas of solid cancer and blood cancer therapy, digital therapeutics/personalised learning, and post-organ transplant immunosuppression, among others.

Prof Ho is an elected member of the US National Academy of Inventors (NAI). Election to the NAI is the highest professional honour for academic inventors. He is also a Fellow of the American Institute of Medical and Biological Engineering (AIMBE) and Society for Laboratory Automation and Screening, as well as a Fulbright Scholar. He is also a recipient of the NSF CAREER Award, Wallace H. Coulter Foundation Translational Research Award, and V Foundation for Cancer Research Scholar Award, among others. Prof Ho was named to the Asia Tatler Gen.T List, which honours young leaders who are shaping the future of the region. Prof. Ho has appeared on the National Geographic Channel Program "Known Universe" to discuss his discoveries in drug delivery and imaging. His discoveries have featured on CNN, The Economist, Forbes, Washington Post, NPR and other international news outlets. He has served as the President of the Board of Directors of the Society for Laboratory Automation and Screening (SLAS), a 26,000+ member global drug development organisation comprised of senior executives from the pharmaceutical and medical device sectors, as well as academic thought leaders.

Harnessing AI to realise globally optimised therapies cheaper and faster to boost patient accessibility, Prof Ho co-founded KYAN Therapeutics, a revenue and clinical-stage biotechnology company. Backed by some of the world's leading healthcare visionaries, KYAN has already shattered the concept of traditional drug development, with a considerable portion of its pipeline as well as its foundational technologies previously clinically validated. KYAN's AI platform recently harnessed to develop a novel infectious disease drug combination that cut patient treatment times in half with orders-of-magnitude reductions in development costs. Prof. Ho has also advised multiple venture capital funds as well as publicly-traded health and technology companies in the areas of AI, digital medicine, and nanomedicine, among others.

Kuldeep Singh Rajpu, Founder & CEO, Biofourmis 


Kuldeep Singh Rajput is the CEO and Founder of Biofourmis, a fast-growing digital health company filled with committed, passionate people who care about augmenting personalised care and empowering people with complex chronic conditions to live better and healthier lives. Biofourmis is pioneering an entirely new category of digital health, by developing clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. 

Recognised as the “Forbes 30 Under 30”, Kuldeep has demonstrated strong leadership experience with building teams, developing talents, and successfully growing, and managing strategic partnerships with global pharmaceutical manufacturers, health systems and Payers. Under his leadership, Biofourmis has raised over $45 Million in venture capital from leading Venture Capital firms, including Sequoia Capital, MassMutual Ventures, Aviva plc, and Mayo Clinic Ventures. 

He uses his background and experience in biomedical engineering and data from the Massachusetts Institute of Technology (MIT) to unfold his vision of “Predicting and Preventing Serious Medical Events using AI”. During his PhD studies at the National University of Singapore (NUS), he built bioelectronic implants, which aim to control biological processes and treat diseases by modulating electric impulses. 

He believes in giving back and is part of the Milken Institute Young Leaders Circle (YLC), supporting the mission of providing people access to education and healthcare for stable economic growth. Kuldeep has been featured in major publications and has been a keynote speaker at numerous prestigious conferences like TED. 

Huub van Esbroeck, Founder, Structo

Huub van Esbroeck is one of the Co-founders of Structo, a world-leading 3D printing solutions provider headquartered in Singapore. Huub has a background in Mechanical Engineering and has obtained B.Eng and M.Sc degrees from the National University of Singapore, where he worked on the development of Structo's proprietary Mask Stereolithography (MSLA) technology; the foundation of Structo's 3D printing solutions for dental and healthcare applications. Huub now leads the company's global team as they bring the "made in Singapore" technology to customers across five continents.

Moderator’s Profile

Dr Lim Jui, CEO, SGInnovate

As CEO of SGInnovate, Dr Lim Jui has overall leadership of the organisation that is committed to helping entrepreneurial scientists build and scale Deep Tech startups. At SGInnovate, Jui and his team work closely with a wide range of partners and co-investors to back this unique group of founders, who are looking to solve global challenges with their research-based solutions. This is done through equity-based investments, access to the Deep Tech ecosystem and talent network, as well as by providing business-building support.

While he trained in medicine, Jui had spent most of his professional life in the business of science and innovation. He was Director of Investments, Bio*One Capital; CEO of Merlin MD, a medical device company; Executive Director of the Medical Engineering Research and Commercialisation Initiative (MERCI) at the National University of Singapore (NUS); and Programme Director of the Singapore-Stanford Biodesign Programme (SSB), a joint venture between the Agency for Science, Technology and Research (A*STAR), the Singapore Economic Development Board (EDB) and Stanford University. Before joining SGInnovate, Jui was CEO of NTUitive, the innovation and enterprise company of the Nanyang Technological University (NTU).

He currently serves on the advisory boards of IPOS International, the business arm of the Intellectual Property Office of Singapore (IPOS), and several startup companies. He was previously a board member of the Building and Construction Authority (BCA) in Singapore.

Jui received his Bachelor of Arts (BA, Biological Sciences and East Asian Studies) and Doctor of Medicine (MD) at Columbia University. He then obtained his Master of Medicine (Anaesthesiology and Surgical Intensive Care) from NUS. He remains a registered medical practitioner today.
A firm believer in National Service (NS), Jui served 22 years as an operationally ready national serviceman (NSMan). In his final appointment as an NSMan, he was the Commanding Officer of an infantry battalion in the Singapore Army. Outside of work, he enjoys spending time with his family and friends over food, drinks and music. He then burns it off by running, most frequently in the trails around MacRitchie Reservoir.

Topics: MedTech / HealthTech / BioTech